XTL Biopharmaceuticals Ltd. Logo

XTL Biopharmaceuticals Ltd.

XTLB | TA

Overview

Corporate Details

ISIN(s):
IL0010854979
LEI:
529900NDDXEAPTUTXP41
Country:
Israel
Address:
5 HaCharoshet St., 4365603 Raanana
Sector:
Health Care
Industry:
Biotechnology

Description

XTL Biopharmaceuticals Ltd. focuses on the development of innovative therapeutics for the treatment of unmet medical needs in Israel.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-15 11:36
Board/Management Change
Immediate Report of Meeting to be held on July 21, 2025
English 735.8 KB
2025-06-15 11:36
Foreign Filer Report
Immediate Report of Meeting to be held on July 21, 2025
English 262.4 KB
2025-06-15 11:36
Declaration of Voting Results & Voting Rights Announcements
Immediate Report of Meeting to be held on July 21, 2025
English 131.2 KB
2025-05-01 01:18
Annual Report
FORM 20-F For the fiscal year ended December 31, 2024
English 5.4 MB
2025-05-01 01:18
Foreign Filer Report
FORM 20-F For the fiscal year ended December 31, 2024
English 36.3 KB
2025-04-07 18:27
Board/Management Change
Noam Band was appointed the Chief Executive Officer, Mr. Band replaces Shlomo S…
English 141.8 KB
2025-04-07 18:27
Foreign Filer Report
Noam Band was appointed the Chief Executive Officer, Mr. Band replaces Shlomo S…
English 36.3 KB
2025-03-04 14:39
Takeover Announcement Report
Definitive Exclusive Sublicense Agreement with Biossil, a company incorporated …
English 116.4 KB
2025-03-04 14:39
Foreign Filer Report
Definitive Exclusive Sublicense Agreement with Biossil, a company incorporated …
English 36.3 KB
2025-02-04 00:17
Takeover Announcement Report
. Tal Klinger’s and Yair Redl’s decisions to resign from the Board were not due…
English 111.2 KB
2025-02-04 00:17
Foreign Filer Report
. Tal Klinger’s and Yair Redl’s decisions to resign from the Board were not due…
English 36.3 KB
2024-12-31 08:29
Foreign Filer Report
6K-financial results for the nine months ended September 30, 2024
English 150.7 KB
2024-12-31 08:29
Foreign Filer Report
6K-financial results for the nine months ended September 30, 2024
English 36.2 KB
2024-12-31 08:27
Foreign Filer Report
6K- financial results for the six months ended June 30, 2024
English 152.3 KB
2024-12-31 08:27
Foreign Filer Report
6K- financial results for the six months ended June 30, 2024
English 36.2 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC